-
475741-10MG
MAGL INHIBITOR III JZL184 - CAS 1101854-58-3 - CALBIOCHEM
Price: $324.13List Price: $360.14A cell-permeable, blood-brain-barrier-permeant, and orally available carbamate compound that selectively inhibit MAGL (monoacylglycerol lipase) activity over FAAH (fatty acid amide hydrolase) and 35 other murine brain serine hydrolases, both in -
16664-10
Mozavaptan (hydrochloride)-10 mg
Price: $191.08List Price: $212.31A benzazepine derivative that antagonizes the binding of AVP to vasopressin V2 receptors (IC<sub>50</sub> = 14 nM) inhibits the antidiuretic action of AVP, promoting aquaresis when administered intravenously to rats at 10-100 µg/kg. -
16664-100
Mozavaptan (hydrochloride)-100 mg
Price: $573.17List Price: $636.85A benzazepine derivative that antagonizes the binding of AVP to vasopressin V2 receptors (IC<sub>50</sub> = 14 nM) inhibits the antidiuretic action of AVP, promoting aquaresis when administered intravenously to rats at 10-100 µg/kg. -
16664-5
Mozavaptan (hydrochloride)-5 mg
Price: $118.58List Price: $131.75A benzazepine derivative that antagonizes the binding of AVP to vasopressin V2 receptors (IC<sub>50</sub> = 14 nM) inhibits the antidiuretic action of AVP, promoting aquaresis when administered intravenously to rats at 10-100 µg/kg. -
16664-50
Mozavaptan (hydrochloride)-50 mg
Price: $309.95List Price: $344.38A benzazepine derivative that antagonizes the binding of AVP to vasopressin V2 receptors (IC<sub>50</sub> = 14 nM) inhibits the antidiuretic action of AVP, promoting aquaresis when administered intravenously to rats at 10-100 µg/kg. -
N480127-1g
N-Methyl-1-(5-methyl-1H-pyrazol-4-yl)methanamine hydrochloride
Price: $581.51List Price: $646.12N-Methyl-1-(5-methyl-1H-pyrazol-4-yl)methanamine hydrochloride. -
Ab183427-100μg
Ponezumab (anti-Amyloid Beta) (C007B-543064)
Price: $182.90List Price: $203.22Ponezumab (anti-Amyloid Beta) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab (anti-Amyloid Beta) reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab -
Ab183427-10mg
Ponezumab (anti-Amyloid Beta) (C007B-543065)
Price: $2,173.91List Price: $2,415.45Ponezumab (anti-Amyloid Beta) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab (anti-Amyloid Beta) reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab -
Ab183427-1mg
Ponezumab (anti-Amyloid Beta) (C007B-543066)
Price: $717.45List Price: $797.16Ponezumab (anti-Amyloid Beta) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab (anti-Amyloid Beta) reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab -
Ab183427-5mg
Ponezumab (anti-Amyloid Beta) (C007B-543067)
Price: $1,410.69List Price: $1,567.43Ponezumab (anti-Amyloid Beta) is a humanised anti-amyloid IgG2 monoclonal antibody. Ponezumab (anti-Amyloid Beta) reduces Aβ levels in the central nervous system and improves performance in mice in various models of learning and memory. Ponezumab -
648493-25MG
TRPM4 INHIBITOR 9-PHENANTHR 1PC X 50MG (C005B-254178)
Price: $359.92List Price: $399.91General description A membrane permeable dihydroquinolinyloxo-isoindolinedione compound that acts as a potent and selective agonist of lysosomal mucolipin transient receptor potential (TRP) channel 1,2,3 (TRPML) in all mammalian cells. Does not